Sign in
VSTM Stock Price, Chart, Stats & News
Verastem, Inc.
Save
Verastem, Inc. (VSTM) does not currently pay a dividend.
415.88M
Market cap
–
Current P/E
–
Forward P/E
VSTM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 83.80% |
Operating margin | -550.32% |
Pretax margin | -677.59% |
Net margin | -677.59% |
Effective tax rate | – |
ROA | -85.00% |
ROE | -1849.88% |
D/E | 1.52x |
Interest coverage ratio | -207.73x |
VSTM valuation
P/E | – |
P/S | 11.30x |
P/B | 7.35x |
P/CF | -3.06x |
P/FCF | -2.54x |
P/OCF | -3.06x |
PEG | -0.07x |
EV multiple | -2.15x |
About
Verastem, Inc. is an emerging biopharmaceutical company dedicated to the creation and commercialization of innovative therapeutic agents for cancer treatment. A primary asset in its pipeline is VS-6766, a novel dual RAF/MEK inhibitor that operates by a "clamp" mechanism. This unique action effectively blocks the kinase activity of MEK and disrupts RAF's ability to phosphorylate MEK.
Similar securities
Based on sector and market capitalization
Report issue